FOR IMMEDIATE RELEASE - July 30, 2024

ElevateQC Introduces Early Adopter Program to

Pioneer New Standards in Lab Quality  

Chicago, IL – [July 30, 2024] – Chicago, IL – As part of our exciting launch at ADLM 2024, ElevateQC is proud to introduce our Early Adopter Program, designed to provide select laboratories with the opportunity to implement and benefit from our groundbreaking quality control platform.

Benefits of Joining the Early Adopter Program:

• Early Access: Be among the first to implement and benefit from ElevateQC’s innovative platform, designed to transform laboratory quality control.

• Cost-Free Participation: Enjoy participation at no charge for up to 12 months, depending on participation and the benefits gained.

• Error Reduction and Cost Savings: Collaborate with us to measure meaningful reductions in blood test errors and realize cost savings.

• Collaborative Research: Work together on medical publications and possible grant applications to further enhance laboratory practices and knowledge.

• Exclusive Support: Receive dedicated support and early access to new features, ensuring optimal use and maximum benefit.

"We are genuinely excited about the Early Adopter Program as it marks a pivotal step in our go-to-market strategy," said John Hopkins, Chief Science Officer of ElevateQC. "This program allows us to directly engage with innovative labs, demonstrating the significant advantages of our platform."

Program Timeline: The Early Adopter Program will begin in the fall of 2024, approximately 8-10 weeks after ADLM.

The Process: We are currently accepting applications for the program and will be selecting an initial set of early adopters to begin working with us. If you are interested in learning more and would like to be considered for the program, please visit us at booth #1926 at ADLM in Chicago this week or visit us at elevate-qc.com.

“Joining the Early Adopter Program offers labs a unique opportunity to be at the forefront of innovation in blood testing,” added Michael Bryce, CEO of ElevateQC. “We look forward to working closely with our early adopters.  Blood testing in the lab can be better and we are excited to collaborate with pioneers to make that a reality.”